IPSC
Century Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.47
+0.68%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-47.3%
Return on equity
-38.3%
Return on assets
-44.5%
Return on invested capital
0.00x
Asset turnover
-$86.7M
Cash from operations
$0.66
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026